Aetna Inc. (NYSE:AET) had its price target upped by investment analysts at Deutsche Bank AG from $144.00 to $157.00 in a research report issued on Thursday, July 13th. The firm currently has a “hold” rating on the stock. Deutsche Bank AG’s price target points to a potential upside of 0.47% from the company’s previous close.

Other analysts have also issued research reports about the company. Stifel Nicolaus lifted their price objective on Aetna from $150.00 to $158.00 and gave the stock a “buy” rating in a report on Tuesday, May 16th. Zacks Investment Research raised Aetna from a “hold” rating to a “buy” rating and set a $143.00 price objective on the stock in a report on Tuesday, April 4th. Royal Bank Of Canada reissued a “buy” rating and set a $145.00 price objective on shares of Aetna in a report on Monday, April 24th. Cantor Fitzgerald reissued a “buy” rating and set a $150.00 price objective on shares of Aetna in a report on Friday, May 12th. Finally, Cleveland Research raised Aetna from a “neutral” rating to a “buy” rating in a report on Thursday, May 11th. Eight research analysts have rated the stock with a hold rating and seventeen have given a buy rating to the company’s stock. The stock presently has an average rating of “Buy” and a consensus price target of $157.09.

Shares of Aetna (NYSE:AET) opened at 156.27 on Thursday. The company’s 50 day moving average price is $153.85 and its 200 day moving average price is $137.83. The firm has a market capitalization of $51.83 billion, a price-to-earnings ratio of 47.66 and a beta of 0.54. Aetna has a 52-week low of $104.59 and a 52-week high of $161.69.

Aetna (NYSE:AET) last released its earnings results on Thursday, August 3rd. The company reported $3.42 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.34 by $1.08. Aetna had a return on equity of 20.52% and a net margin of 2.52%. The firm had revenue of $15.52 billion for the quarter, compared to analyst estimates of $15.34 billion. During the same quarter last year, the firm posted $2.21 EPS. The company’s revenue was down 2.7% on a year-over-year basis. Analysts forecast that Aetna will post $9.43 earnings per share for the current year.

TRADEMARK VIOLATION WARNING: “Aetna Inc. (NYSE:AET) Price Target Raised to $157.00 at Deutsche Bank AG” was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are accessing this piece on another site, it was illegally copied and reposted in violation of United States and international trademark and copyright legislation. The original version of this piece can be viewed at https://www.thecerbatgem.com/2017/08/09/aetna-inc-nyseaet-price-target-increased-to-157-00-by-analysts-at-deutsche-bank-ag-updated-updated-updated.html.

In other news, Chairman Mark T. Bertolini sold 103,547 shares of the business’s stock in a transaction on Wednesday, May 17th. The stock was sold at an average price of $140.79, for a total transaction of $14,578,382.13. Following the completion of the sale, the chairman now owns 659,888 shares in the company, valued at $92,905,631.52. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Also, EVP Margaret M. Mccarthy sold 27,028 shares of the business’s stock in a transaction on Wednesday, June 7th. The stock was sold at an average price of $149.23, for a total value of $4,033,388.44. Following the sale, the executive vice president now owns 33,563 shares of the company’s stock, valued at approximately $5,008,606.49. The disclosure for this sale can be found here. Insiders own 1.14% of the company’s stock.

Large investors have recently added to or reduced their stakes in the company. Gulf International Bank UK Ltd boosted its stake in shares of Aetna by 1.3% in the first quarter. Gulf International Bank UK Ltd now owns 109,635 shares of the company’s stock worth $13,983,000 after buying an additional 1,450 shares during the period. Creative Planning boosted its stake in shares of Aetna by 13.3% in the first quarter. Creative Planning now owns 16,574 shares of the company’s stock worth $2,114,000 after buying an additional 1,946 shares during the period. Raymond James Trust N.A. boosted its stake in shares of Aetna by 8.4% in the first quarter. Raymond James Trust N.A. now owns 6,641 shares of the company’s stock worth $847,000 after buying an additional 514 shares during the period. Chevy Chase Trust Holdings Inc. boosted its stake in shares of Aetna by 3.3% in the first quarter. Chevy Chase Trust Holdings Inc. now owns 309,206 shares of the company’s stock worth $39,439,000 after buying an additional 9,813 shares during the period. Finally, Atalanta Sosnoff Capital LLC bought a new stake in shares of Aetna during the first quarter worth approximately $23,446,000. Institutional investors own 91.73% of the company’s stock.

About Aetna

Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.

Analyst Recommendations for Aetna (NYSE:AET)

Receive News & Stock Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related stocks with our FREE daily email newsletter.